# Corey Cutler

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/corey-cutler/

## Facts

| Field | Value |
| --- | --- |
| Citations | 42,349 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 106 |
| i10-index | 351 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5029278364 |
| ORCID iD | https://orcid.org/0000-0001-8728-4314 |
| Works | 836 |

## Researcher papers

- [National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report](https://scholariq.org/papers/national-institutes-of-health-consensus-development-project-on-criteria-for/)
- [Risk factors for acute GVHD and survival after hematopoietic cell transplantation](https://scholariq.org/papers/risk-factors-for-acute-gvhd-and-survival-after-hematopoietic-cell/)
- [Ibrutinib for chronic graft-versus-host disease after failure of prior therapy](https://scholariq.org/papers/ibrutinib-for-chronic-graft-versus-host-disease-after-failure-of-prior-therapy/)
- [Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research](https://scholariq.org/papers/increasing-incidence-of-chronic-graft-versus-host-disease-in-allogeneic/)
- [Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study](https://scholariq.org/papers/belumosudil-for-chronic-graft-versus-host-disease-after-2-or-more-prior-lines-of/)
- [Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia](https://scholariq.org/papers/allogeneic-transplantation-for-therapy-related-myelodysplastic-syndrome-and/)
- [Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium](https://scholariq.org/papers/nonrelapse-mortality-among-patients-diagnosed-with-chronic-gvhd-an-updated/)
- [Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease](https://scholariq.org/papers/axatilimab-in-recurrent-or-refractory-chronic-graft-versus-host-disease/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.